Article Text

See original article:

Download PDFPDF
The F158V polymorphism in FcγRIIIA shows disparate associations with rheumatoid arthritis in two genetically distinct populations

Abstract

Objectives: To investigate the association of the FcγRIIIA gene with rheumatoid arthritis (RA) in two genetically distinct groups: a white group from the United Kingdom and a northern Indian group.

Methods: The distributions of the two alleles of the FcγRIIIA F158V polymorphism were determined in 398 white patients from the United Kingdom and 63 Indian patients with RA and compared with those from 289 United Kingdom and 93 Indian healthy controls, respectively.

Results: Among the Indian patients, the frequency of the rare 158V allele and the proportion of 158VV homozygotes were reduced (relative risk (RR)=0.3, 95% confidence interval (95% CI) 0.1 to 1.1, p<0.06), reaching statistical significance for carrying the 158VV phenotype relative to 158FV or FF (RR=0.2, 95% CI 0.05–0.9, p<0.02). Conversely, no significant deviation in allelic frequencies was noted between the patients and controls from the United Kingdom.

Conclusions: The 158VV phenotype showed a weak protective effect against developing RA in the Indian group. However, this sample was small (resulting in a low power for statistical analysis) and no independent confirmation was found in the larger white United Kingdom group. Thus the FcγRIIIA locus is unlikely to be of major importance in causing RA.

  • FcγRIIIa
  • polymorphism
  • rheumatoid arthritis
  • genetics
  • ADCC, antibody dependent cytotoxicity
  • CI, confidence interval
  • F, phenylalanine
  • FcγRIIIA, Fcγ receptor IIIA
  • ICA, immune complex mediated arthritis
  • IL2, interleukin-2
  • NK, natural killer
  • OR, odds ratio
  • PCR-RFLP, polymerase chain reaction restriction fragment length polymorphism
  • RA, rheumatoid arthritis
  • RF, rheumatoid factor
  • RR, relative risk
  • SLE, systemic lupus erythematosus
  • V, valine

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles

  • Correction
    BMJ Publishing Group Ltd and European League Against Rheumatism